E7 TCR-T Cell Immunotherapy

E7-targeted TCR-T cells

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for E7 TCR-T Cell Immunotherapy, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers [Phase 2]